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TETRASTYRYL-BODIPY DYES AS POTENTIAL 
PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY 
 
Nisa Yeşilgül 
M.S. in Department of Chemistry 
Supervisor: Prof. Dr. Engin U. Akkaya 
August, 2011 
 
Photodynamic therapy (PDT) is a novel methodology for a wide range of 
treatments of cancerous and noncancerous diseases. Success of treatment and 
photodynamic action is highly dependent the performance of PDT agents. 
Therefore, PDT agents with unique photophysical properties are required in 
clinical applications. There are several photosensitizers in literature and some 
are available. However, most of them less than ideal due to limitations such as 
low molar absorptivity and photo stabilities.  
In this study, we synthesized near-IR tetrastyryl-Bodipy derivatives as 
photosensitizers. These sensitizers have strong absorption in therapeutic region 
and are good photo-generator of singlet oxygen. They are promising for 
photodynamic therapy with their favorable properties. 
 
 
Keywords: Boradiazaindacene (Bodipy), photodynamic therapy (PDT), 
photosensitizer (PS), singlet oxygen. 
 
 
 
 
 
  
 
ÖZET 
 
FOTODĐNAMĐK TERAPĐ ĐÇĐN POTANSĐYEL 
FOTODUYARLAŞTIRICI OLAN TETRASTĐRĐL-
BORADĐAZAĐNDASEN  
Nisa Yeşilgül 
Yüksek Lisans, Kimya Bölümü 
Tez Yöneticisi: Prof. Dr. Engin U. Akkaya 
Ağustos, 2011 
 Fotodinamik terapi bir çok kanser tipi ve kanser tipi olmayan hastalık 
tedavisinde kullanılan bir tedavi yöntemidir. Tedavinin, dolayısıyla fotodinamik 
uygulamanın başarısı fotoduyarlaştırıcıya bağlıdır. Bu yüzden klinik 
uygulamalarda kullanılacak fotoduyarlaştırıcıların belirli özelliklerinin olması 
gereklidir. Çok sayıda yayınlanmış fotoduyarlaştırıcı çeşidi vardır. Fakat çoğu 
düşük molar absortivite ve foto-kararlılık nedeniyle yetersizdir. 
Bu çalışmada, yakın kızıl ötesi absorbansları olan yeni tetrastiril-Bodipy 
fotoduyarlaştırıcıları sentezlenmiştir. Bu duyarlaştırıcıların teröpatik aralıkta 
yüksek absorbansı vardır. Bu olumlu özellikleriyle, bunlar fotodinamik terapi 
için ümit vaadetmektedirler. 
 
Anahtar Kelimeler: Bodipy, fotodinamik terapi, fotoduyarlaştırıcı, singlet 
oksijen    
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 CHAPTER 1 
 
ITRODUCTIO 
 
1.1. Photodynamic Therapy 
 
Light has been used in the treatment of certain diseases since old times. 
However, its popularity of use in medicine has been increased considerably in 
recent years. 

 Photodynamic therapy (PDT) is a promising treatment for cancer 
and some other diseases involves a photosensitizer (PS), a light activable 
chemical, and light at a specific range of wavelength.  
In clinical applications, photosensitizer can be applied intravenously or 
topically and then light is illuminated to the specific tissue. Therefore, 
photosensitizer is activated by visible or nearly visible light resulting with 
reactive oxygen species, singlet oxygen (O2
1) species.

 
Cell death in the presence of intense light was first reported by Oscar 
Raab in literature.
, During his study on the effects of acridine on malaria, he 
observed toxic effects of acridine red molecule on certain bacteria in the 
presence of light.

 By these control experiments, requirement of fluorophore for 
the light induced toxicity was proved. After these discoveries, eosin became the 
first photosensitizer, which was used for medical purposes by Tappeiner and 
Jesionek and also essential participation of oxygen is realized by Tappeiner and 
Jodbauer.

 However, the role of the oxygen in the mechanism of oxygen-
dependent toxicity of photoactive molecules is resolved at 1979 by electron spin 
resonance technique.

  By this technique generation of singlet oxygen, which is 
highly reactive excited state oxygen, is monitored. 
The first clinical application of photodynamic therapy was conducted at 
Roswell Park Cancer Institute in 1978, following this application, photofrin is 
approved by United States FDA as a photosensitizer in 1980.

  Since that time a 
 number of photosensitizers such as HPPH, ALA, Metvix are approved by FDA 
and reported in literature (Figure 1). 
 
Figure 1. Different type of photosensitizers 
 
 
 1.1.1. Mechanism of Photodynamic Action 
 
The generation of reactive singlet oxygen species is the crucial step of 
photodynamic action.9-16 The process start with excitation of photosensitizer via 
photon at appropriate energy, usually between 600-800 nm, from its ground state 
to singlet excited state following with relaxation to ground state vibrational level 
of excited electronic state (Figure 2). There are three possible ways that electron 
can follow at this point. It can go back to its ground state, nonradiative internal 
conversion or it can fall back to its ground state, fluorescence, or it can go to 
triplet excited state, intersystem crossing. Intersystem crossing can result with 
phosphorescence or in a way of favorable for photodynamic action if energy is 
transferred to ground state of oxygen resulting with reactive oxygen species.

 
Figure 2. Jablonski energy diagram16 
 Besides singlet oxygen generation from direct energy transfer of excited 
photosensitizer to oxygen molecule, singlet oxygen can also be generated by 
energy transfer from photosensitizer to other biomolecules or substrates in the 
environment.

 Therefore, formed unstable radicals can react with other 
biomolecules and substrates or molecular oxygen, as a result singlet oxygen 
generation is provided. 
The interactions of singlet oxygen species with other cells result with 
cytotoxic effects for both targeted tumor cells and surrounding cells besides 
these direct cytotoxic effects of photodynamic therapy, they trigger 
immunological response to tumor regions by preventing vascular supplements to 
the cancerous tissues.

 This action triggers two types of cell deaths, apoptosis 
and necrosis (Figure 3). 

, 

 
 
Figure 3. Biological response of photodynamic therapy11 
 
 Apoptosis is a programmed cell death and it is characterized by cell 
shrinkage and nuclear fragmentation. Necrosis, on the other hand, is a traumatic 
cell death and it is characterized by swelling of the cell. In contrast to necrosis, 
apoptosis produces apoptotic cell fragments that clean the contents of the cell 
before they are spill out to surrounding tissues. 
1.1.2. Light and Photosensitizer 
Careful control of light and photosensitizer is very important for the 
success of photodynamic applications. 
1.1.2.1. Ligth 
Light interaction with a tissue can result by absorption, scattering, 
transmission or reflection depending on the light properties such as absorption 
coefficient and on the optical features of the tissue (Figure 4). Inhomogeneous 
sides such as membranes and nuclei affect the propagation of light in the tissue 
by causing scattering. Moreover, existence of water or some endogenous dyes 
such as melanin in the tissue affect the penetration depth of light.9  
                       
Figure 4. Light interactions on tissue9 
 
 In a general consideration, however, light in the spectral range of 600-
700 nm penetrates 50-200% more according to the light in the spectral range of 
400-500 nm.

 Laser or other sources such as light-emitting diodes (LEDs) can 
be used as the light sources for photodynamic application. 
 
1.1.2.2.    Photosensitizers 
In the phototherapeutic window, 620-850 nm, light penetrates in the 
maximum depth when certain biomolecules are considered such as melanin, 
collagens, nicotinamide, flavins (Figure 5).9,

.

 Photosensitizers activated by 
visible or near visible light attack surrounding cancer cells stimulate immune 
system. Besides, absorption of photosensitizers in the 400-600 nm range should 
be low to avoid prolonged skin sensitivity.  As the efficiency of photosensitizer 
is considered, it should be very pure and stable. Besides these properties 
photosensitizers should be water-soluble for medical uses and should be 
ineffective until light is applied (nontoxic in the dark).1, 9  
 
 Figure 5. Dye families in the visible region16 
 
Photofrin, and hematoporphyrin derivatives are the first generation 
photosensitizers, however, these type of photosensitizers have low absorption in 
the phototherapeutic window and also cause 2- 3 months of skin sensitivity 
(prolonged skin sensitivity).17-21 The second generation of photosensitizers is 
based on porphyrin derivatives, which have a better absorption in the 
phototherapeutic window.18 In the third generation, photosensitizers linked to 
biomolecules so that a better selectivity is provided.19 
Several groups of photosensitizers are studied in clinical applications; 
bacteriochlorins, phthalocyanines, naphthalocyanines, andtexaphyrins are some 
of them (Table 1).11,12, 18 
 
 
  
Table 1. Some photosensitizers are used in clinical applications.18 
 
Xanthane derivative (fluorescein, eosin and Rose Bengal) , Cyanine 
dyes, hypericin, squaraines, texaphyrins, fullerenes, Bodipy derivatives and 
Perylenediimide can be listed as some of the several sensitizers in the 
literatures.
 ,  Perylendiimide dyes are promising when their high quantum 
 yields are considered, besides their absorption maxima can be shifted to the 
therapeutic window with proper functionalization (Figure 6).19  
Figure 6. Photosensitizers in literature. 
 
1.2. Bodipy dyes 
4,4’-difluoro-4-bora-3a,4a-diaza-s-indacene, abbreviated to Bodipy, dyes 
have gained considerable attention over several fluorescent organic molecules 
within the last decade. As bright fluorescent dyes, Bodipy dyes were used in 
cellular imaging for several years after their first synthesis by Treibs and 
Kreuzer in 1968. 

,

 However, Bodipy dyes have been used in many 
applications within the last decade.

  
 
  
1.2.1. Functionalization 
 
The ease of functionalization from different positions is one of the 
important features of Bodipy dyes make them favorable to use in different areas. 
There are several literature examples of Bodipy derivatives functionalized from 
different positions (Figure 7).27-40 
 
Figure 7. Functionalization of Bodipy dye 
The substitution of aryl groups on the meso position has little effect on 
the absorption and emission bands. However, quantum yields of 1, 7- 
substitution of these Bodipy derivatives are more than the unsubstituted ones 
because 1, 7-substitutions prevent free rotation of the phenyl ring (Figure 8).27 
 
Figure 8. Bodipy derivatives in literature. Quantum yields of compound 1a and 
1b; 0.19 and 0.65 in MeOH, respectively. 
  
The 2, 6- positions of Bodipy dyes can be sulfonated by electrophilic 
reaction with chlorosulfonic acid, as a result, sulfonated Bodipy derivative is 
more stable than the Bodipy core besides water solubility of functionalized 
Bodipy derivative are increased (Figure 9).

,
 
  
Figure 9. Sulfonated Bodipy derivatives in literature. 
 
Bromination or Iodination of Bodipy core gives dibromination, 
diiodination at 2, 6-positions. These kind of functionalized Bodipy derivatives 
have showed a significant red shift of absorption and emission maxima (Figure 
10).

  
Figure 10. Bromination or Iodination on Bodipy core 
The substitution of 3- and 5- positions has an important effect on shifting 
emission and absorption spectra and on fluorescent quantum yields. The 
substitution of electron donating groups such as thioalkoxides or amino groups 
to the 3- and 5- positions creates a significant bathochromic shift of both 
emission and absorption spectra (Figure 11).

  
  
Figure 11. The substitution of 3- and 5- positions on Bodipy core in literature. 
The acidic character of methyl groups at 3- and 5- positions of Bodipy 
derivative gives a high yield with Knoevenagel reactions. Therefore, different 
styryl substituted Bodipy derivatives can be synthesized by using several 
aldehydes (Figure 12).29-33 Functionalization at 3- and 5 positions are also 
possible with transition metal catalyzed reactions such as Suziki, Sonagashira, 
Stille and Heck couplings.

 Therefore, series of Bodipy dyes with extended 
conjugation and dispersed emission maxima have synthesized.  
 
 
  
Figure 12. Different Bodipy derivatives substituted on 3, 5- positions in 
literature. 
The functionalization on the positions of fluoride ions of boron center at 
the Bodipy derivative is also possible (Figure 13). Ziessel and coworkers have 
replaced fluoride ions by aryl, ethynyl, and ethynylaryl substituents.31-36 
  
Figure 13. The functionalization on fluoride ions of Bodipy core in literature. 
         
1.2.2. Applications of Bodipy Dyes 
 Their several distinctive properties such as their high fluorescent quantum 
yields, narrow emission bands, thermal and photostabilities, solubility and ease 
of functionalizations make Bodipy dyes convenient and popular in many 
different applications over commonly used fluorescent organic compounds. 
They are used as fluorophores in different kind of applications such as energy 
transfer systems, light emitting devices, mesomorphic materials, biochemical 
labeling, light harvesting systems, photodynamic therapy applications and solar 
cell applications. 
 
  
1.2.2.1. Light harvesting systems and Energy transfer 
   
Light harvesting systems as a mimic of natural systems are made up join 
of fluorescent units, donors and acceptors, with mutual spectral properties. 
Spectral overlap of donor emissions and acceptor absorbances and the distance 
between these units are important for the effectiveness of the energy transfer 
system. Akkaya et al. synthesized a dendritic light harvesting system, which 
consists of four Bodipy units as donors and a perylendiimide core as acceptor 
(Figure 14).45 Because of the increased number of Bodipy dyes on the structure, 
extinction coefficient of the system at the maximum absorption of Bodipy dye 
(526 nm) is increased to 240000 M-1cm-1 and energy transfer efficiency is found 
to be 99%. 
Figure 14. A Bodipy based dendritic light harvesting system.45 
 
Here is another example of light harvesting system containing Bodipy 
dyes as donors. The energy is transferred to zinc porphyrin from Bodipy dye and 
then it is transferred to a fullerene (Figure 15).46 In this synthetic system, protein 
matrix is not required because chromophores are self assembled for 
coordination.  
 
  
 
 
Figure 15. Artificial antenna46 
 
1.2.2.2. Solar cells 
 Dye synthesized solar cells has received a considerable interest  as an 
alternative to the semiconductor based solar cells in recent years due to their low 
cost. In order to increase the efficiency of the dye synthesized solar cell systems, 
several groups are incorporated such as a zinc porphyrin Bodipy dyad 
application to a dye sensitized solar cell (Figure 16).

 
 
 
 
 
 
 
  
 
 
Figure 16. Zinc porphyrin Bodipy dyad.47 
 
1.2.2.3. Chemosensors 
Fluorescent chemosensors have attracted great interest not only for 
scientific but also commercial tools for biomedical applications since their first 
literature examples in 1980 by Tsien. First Bodipy based chemosensors are 
synthesized by Daub in 1997.48 Since then Bodipy based chemosensors are used 
sensing of different kind of cations and anions and as pH indicators (Figure 17).  
 
Figure 17. Bodipy based chemosensor. 
 
  
1.3.  Photodynamic therapy, Bodipy derivatives as 
Photosernsitizers 
Bodipy dyes have received considerable attention within the last decade 
due to their sharp fluorescence emissions, high quantum yields and other 
distinctive properties mentioned before.49 There are different Bodipy derivatives 
have emissions between 530 nm and 630 nm.50  
There are several literature examples of use of Bodipy derivatives as 
photosensitizers in recent years. Azaboradiazaindacenes, aza- Bodipy 
derivatives, are studied extensively by O’Shea and coworkers, compound 18.51,52 
These dyes show a favorable characteristic for photodynamic therapy 
applications with their sharp absorption at therapeutic window (Figure 18). 
 
 
  
Figure 18. Bodipy based photosensitizers in literature. 
  
Akkaya et al. synthesized a photosensitizer by functionalization of 
Bodipy dye (Figure 19).53 The photosensitizer can detect acidity and the sodium 
concentration of the medium. In the acidic environment, pyridine groups are 
protonated and this protonation results with a bathachromic shift of the 
absorbance. These protonated molecules, but not the others, can be activated by 
light at 660 nm. Therefore, these excited molecules induce the photodynamic 
action and photo-induced electron transfer (PET) is prevented by sodium 
binding crown ether moieties. In cancer tissues, pH is low and Na+ concentration 
is high. Therefore, when light is applied at 660 nm, the photosensitizer is 
activated and singlet oxygen generation is provided. 
  
Figure 19. Photosensitezer working according to cancer parameters.53 
 
1.3.1. Tetra-styryl Bodipy Dyes 
Fluorescent probes in the near-IR region are important for photodynamic 
therapy. For instance, during intracellular imaging, emissions obscure below 
approximately 550 nm due to autofluorescence of cells, which makes difficult to 
visualize in vivo, but at longer wavelengths it becomes less. Therefore, Bodipy 
dyes, which have emission in 530 nm- 630 nm, are suboptimal for tissue 
imaging.  
Extending their absorption and emission maxima to the near-IR region 
have been achieved by replacement of carbon in the eight position by a nitrogen 
atom, synthesis of aza-Bodipy derivatives,54,55 , replacement of pyrole by 
isoindole
 
 

, attachment of some aromatic rings to Bodipy core58,59, substitution 
at meso-, 2, 6- and 3, 5- positions of Bodipy core60. The substitution with aryl 
groups at the 8 position on the Bodipy core has little effect on extending 
absorption and optical properties of Bodipy derivatives unless electron donating or 
electron withdrawing substituent such as NO2, CN
61,62.  
  
 
It is possible to synthesize tetrastyryl Bodipy dyes bearing same or 
different side arms and with a proper functionalization is possible to generate 
and to enhance desired chemical properties such as water solubility (Figure 
20).63 
 
 
Figure 20. Tetrastyryl-Bodipy dyes bearing same and different side arms 
 
Knoevenagel reaction is a high yielding method for the substitution at the 
3- and 5- positions of Bodipy core.64-66 It is a simple condensation reaction, 
which is a nucleophilic addition of an active hydrogen compound to a carbonyl 
compound. Mono-, di-, tri-, and tetrastyryl-Bodipy derivatives can be 
synthesized in one reaction by stopping reaction at several times.67-69  
3-, and 5- positions on the Bodipy core yield first in Knoevenagel 
reaction because these positions are the most acidic ones according to  Mulliken-
charge analysis on the core carbon atoms of tetramethyl-Bodipy. Mulliken-
charge analysis is showed the electron density changes in the following order 
according to the positions on Bodipy dye: 2, 6>> 1, 7>> 3, 5.70 1H NMR spectra 
also provides additional information about the acidity of methyl substitutents 
(Figure 21). 
  
Figure 21. Tetramethyl- and pentamethyl Bodipy derivatives with 1H NMR 
chemical shifts in CDCl3.
70 
 
The first example of functionalization on 1, 3, 5, 7- positions on Bodipy 
core published by Akkaya et al. in 2009 although several literature examples of 
3, 5-functionalized Bodipy examples exist.70 Therefore, absorption and emission 
wavelength of synthesized Bodipy dyes were up to 700 nm before this study. In 
Akkaya Research Group’s study, 1, 3, 5, 7-tetra styryl and 3, 5, 7- tristyryl 
Bodipy derivatives  besides 3- mono styryl and 3, 5- distyryl Bodipy derivatives 
were synthesized.  
With a proper combination of the substitutents on side arms, optical 
properties of tetrastyryl-Bodipy derivatives can be improved tremendously. 
Absorption and emission maxima can be tuned and each arm can be sensitive to 
environment at a pH range.  
Zissel et al. synthesized tetrastyryl-Bodipy derivatives, bearing same and 
four different aldehydes in their side arms starting from tetramethyl Bodipy 
derivative (Figure 22).71By using different aldehyhdes in substitution of the side 
arms, mono-, di-, tri- and tetra- styryl substituted derivatives can be achieved to 
synthesize. 
 
  
Figure 22. Tetra- styryl substituted Bodipy derivatives from literature71  
 
Tetrastyryl-Bodipy dyes have unique peaks belong to trans coupled 
protons of methyl groups on 1, 7- positions in 1H NMR spectrum, which is used 
characterization of these dyes. In Figure 23, there are 1H NMR spectra of 
distyryl- and tetrastyryl Bodipy derivatives. There is a shift to downfield, 8.6 
ppm, in both spectra come from protons that are on the side of fluorine atoms 
due to electron withdrawing ability of fluorine atoms. The other protons, which 
do not close to fluorine atoms, give peak in the same region, 7.8 ppm.  Coupling 
constants of these protons are 16 MHz because they are trans to each other. In 
1H NMR spectrum of tetrastyryl-Bodipy dye, however, there is a upfield shift, 
6.05 ppm, come from protons marked in pink due to shielding zone of phenyl 
ring at the meso position. The other proton (marked in green) is not affected 
from the phenyl ring on the meso position so it gives a peak in a similar region 
(7.8 ppm) with trans coupled protons (marked in blue) and again coupling 
constants are 16 MHz, which show trans positions of these protons.  
  
Figure 23. 
1H NMR spectra of distyrl- and tetrastyryl- Bodipy dyes.70 
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2. CHAPTER 2 
EXPERIMETAL 
2.1. General 
 
All chemicals and solvents obtained from Sigma-Aldrich were used 
without further purification. Thin layer chromatography by Merck TLC Silica 
gel 60 F254 was used to monitor reactions. Chromatography on silica gel was 
used over Merck Silica gel 60 (particle size: 0.040-0.063 mm, 230-400 mesh 
ASTM). 1H NMR and 13C NMR spectra were recorded at room temperature on 
Bruker DPX-400 (operating at 400 MHz for 1H NMR and 100 MHz for 13C 
NMR) in CDCl3 with tetramethylsilane (TMS) as internal standard. Coupling 
constants (J values) are given in Hz and chemical shifts are reported in parts per 
million (ppm). Splitting patterns are designated as s (singlet), d (doublet), t 
(triplet), q (quartet), m (multiplet), and p (pentet). Absorption spectra in solution 
were acquired using a Varian spectrophotometer. Varian Eclipse 
spectrofluorometer was used to determine the fluorescence emission spectra. All 
spectroscopy experiments were performed using spectrophotometric grade 
solvents. Mass spectroscopy measurements were conducted using MSBQTOF at 
Bilkent University, UNAM, Mass Spectrometry Facility 
 
 
 
 
 
 
 
 
 
 
 
  
2.2. Synthesis Scheme 
Figure 24. Synthesis Scheme for compound 31 and 32 
  
2.3. Syntheses 
3,5-Bis(decyloxy)benzyl alcohol (compound 22) and 3,5-
Bis(decyloxy)benzaldehyde (compounds 23) were synthesized according to 
literature.70 
2.3.1.  Synthesis of Compound 25  
 
Argon gas was degassed through solution of 400 mL CH2Cl2. 2,4-dimethyl 
pyrrole (29) (15.8 mmol, 1.5 g) and 3,5-bis(decyloxy)phenylbenzaldehyde (30) 
(7.17 mmol, 3.0 g) were added. Then, 1-2 drops of TFA was added to the 
reaction mixture. The reaction mixture was stirred under N2 atmosphere 
overnight at room temperature. DDQ (7.17 mmol, 1.63 g) is added to the 
reaction mixture, and stirring was continued for 30 min. Then Et3N (5 mL) and 
BF3.OEt2 (5 mL) were added, respectively. 100 mL of water was added to the 
reaction mixture and extracted with CHCl3 (3 x 100 mL). Na2SO4 was used as a 
drying agent. The solvent was evaporated and the residue was purified by silica 
gel column chromatography using 2:1 CHCl3 : Hexane as the eluant afforded  
desired product as red solid (1.381 g, 30%). 
  1H NMR (400 MHz, CDCl3): δH 6.45 (s, 1H, ArH), 6.35 (s, 2H, ArH), 5.90 
(s, 2H, ArH), 3.85 (t, 4H, J = 6.56 Hz, OCH2), 2.47 (s, 6H, CH3), 1.70 (m, 4H, 
CH2), 1.49 (s, 6H, CH3), 1.35 (m, 4H, CH2), 1.20 (s, 24H, CH2), 0.80 (t, 6H, J = 
6.5 Hz, CH3). 
13C NMR (100 MHz, CDCl3): δC 161.2, 155.4, 143.2, 136.4, 131.2, 
121.0, 106.4, 102.3, 68.4, 31.9, 29.6, 29.5, 29.3, 29.2, 26.0, 22.7, 14.6, 14.2, 
14.0 ppm. 
 
MS (TOF- ESI): m/z: : Calcd: 636.4638 [M-H]+, Found: 636.4564 [M-
H]+ , ∆=11.6 ppm. 
  
 
Figure 25. Synthesis of Compound 25 
2.3.2. Synthesis of Compound 26 
Compound 25(0.70 mmol, 420 mg) is dissolved in dichloromethane(15 
ml) and dimethylformamide (15 ml) mixture. To the reaction mixture, -
Bromosuccinimide (1.96 mmol, 348.8 mg) dissolved in 10 ml dichloromethane 
is added dropwise. Reaction is monitored by using thin layer chromatography 
until all the starting material is consumed. 50 mL of water was added to the 
reaction mixture and extracted with CH2Cl2 (3 x 50 mL). Na2SO4 was used as a 
drying agent. The solvent was evaporated and the residue was purified by silica 
gel column chromatography using 2:1 CHCl3 : Hexanes as the eluant afforded  
desired product as red solid (500 mg, 90%). 
1H NMR (400 MHz, CDCl3): δH 6.60 (s, 1H, ArH), 6.40 (s, 2H, ArH), 3.95 
(t, 4H, J = 6.64 Hz, OCH2), 2.62 (s, 6H, CH3), 1.79 (m, 4H, CH2), 1.58 (s, 6H, 
CH3), 1.45 (m, 4H, CH2), 1.30 (s, 24H, CH2), 0.88 (t, 6H, J = 6.64 Hz, CH3). 
13C NMR (100 MHz, CDCl3): δC 161.4, 153.8, 142.1, 140.7, 135.7, 130.1, 
106.0, 102.6, 77.3, 77.0, 76.7, 68.5, 31.9, 29.7, 29.6, 29.5, 29.4, 29.3, 29.1, 26.0, 
22.7, 14.1, 13.7, 13.6 ppm. 
MS (TOF- ESI): m/z: : Calcd: 790.2794 [M-H]-, Found: 790.2811 [M-H]-  
∆=2.2 ppm. 
 
 
  
 
Figure 26. Synthesis of Compound 26 
 
 
2.3.3. Synthesis of Compound 29 
A mixture of 4-hydroxybenzaldehyde (1.00g, 8.19mmol), 2-
ethylhexylbromide (1.58g, 8.19mmol), K2CO3 (2.38g, 17.20mmol) and 
acetonitrile (30mL) was reﬂuxed for 1 day under N2. Solvent was evaporated 
and water was added. Reaction product was extracted into CH2Cl2. The organic 
layer was dried over Na2SO4 and after the evaporation of the solvent, silica gel 
column chromatography using CHCl3 as the eluant afforded desired product 
(1.29g,67%).  
1H NMR (400 MHz, CDCl3): δH  9.90 (1H,s), 7.90 (2H, d, J = 6.64 Hz, 
ArH),  7.01 (2H, d, J = 8.68 Hz, ArH), 3.96 (d, 2H, J = 5.7 Hz, OCH2), 1.80 (m, 
1H, CH), 1.48 (m,4H, CH2), 1.32 (m,4H, CH2), 0.96 (t, 6H, J = 3.88 Hz,CH3).  
13CNMR (100 MHz, CDCl3): δC  190.8, 164.5, 132.0, 129.7, 114.8, 77.4, 
77.0, 76.7, 70.9, 39.3, 30.5, 29.0, 23.8, 23.0, 14.1, 11.1. 
MS (TOF- ESI): m/z: : Calcd: 235.1721 [M-H]-, Found: 235.1693 [M-
H]+  ∆= -12.01 ppm. 
 
 
 
  
Figure 27. Synthesis of Compound 29 
 
2.3.4. Synthesis of Compound 31 
To the mixture of compound 26 (0.19 mmol, 150 mg), 4- methoxy 
benzaldehyde (1.33 mmol, 181 mg) and benzene (50 mL)  in a 100 mL round 
bottomed flask, piperidine (0.4 mL) and acetic acid (0.4 mL) were added and 
then the mixture was reflux by using a Dean Stark trap and reaction was 
monitored by TLC 3:1, CHCl3 : Hexanes until all the starting material had been 
consumed, the mixture was cooled to room temperature and solvent was 
evaporated under vacuum. Water (100 mL) was added to the residue and the 
product was extracted into the chloroform (3 x 100 mL). The organic layer was 
dried over Na2SO4 and after the evaporation of the solvent, silica gel column 
chromatography using 3:1 CHCl3 : Hexanes as the eluant afforded desired 
product. Deep green solid (70 mg, 29%).  
1H NMR  (400 MHz, CDCl3): δ = 8.15 (2H, d; J = 16.5 Hz, CH), 7.70 
7.60 (6H, m; 2H: CH, and 4H: ArH), 7.05 (2H, d; J = 16.5 Hz, CH), 7.02, 6.92 
(8H, m; ArH), 6.78 (4H, d; J = 8.8 Hz, ArH),  6.49 (3H, s; ArH), 5.88 (2H, d; J = 
16.5 Hz, CH), 3.89 (6H, s; OCH3), 3.82 (6H, s; OCH3), 3.67 (4H, t; J = 6.6 Hz, 
OCH2), 1.60, 1.50 (4H, m; CH2), 1.35, 1.15 (28H, m; CH2), 0.87 (6H, t;  J = 6.9 
Hz, CH3); 
13C NMR (100 MHz, CDCl3): δ = 161.4, 160.8, 159.8, 149.5, 139.2, 
136.0, 134.8, 129.8, 129.3, 128.0, 118.3, 116.1, 114.3, 113.8, 108.1, 103.3, 68.5, 
55.4, 55.3, 31.9, 29.6, 29.4, 29.3, 29.0, 25.9, 22.9, 14.1.  
MS (TOF  ESI): m/z: : Calcd: 1263.4491 [M]+, Found: 1263.4558 [M] , 
I=5.39 ppm.   
  
Figure 28. Synthesis of Compound 31 
 
2.3.5. Synthesis of Compound 32 
Compound 26 (0.19 mmol, 150 mg) and compound 29 (1.33 mmol, 311 
mg) are added to   a 100 mL round bottomed flask containing benzene (50 mL), 
then  piperidine (0.4 mL) and acetic acid (0.4 mL) were added and the mixture 
was reflux by using a Dean Stark trap and reaction was monitored by TLC 3:1, 
CHCl3 : Hexanes until all the starting material had been consumed, the mixture 
was cooled to room temperature and solvent was evaporated under vacuum. 
Water (100 mL) was added to the residue and the product was extracted into the 
chloroform (3 x 100 mL). Organic phase dried over Na2SO4, evaporated and 
residue was purified by silica gel column chromatography using 3:1 CHCl3 : 
Hexanes as the eluant afforded  desired product as green solid (97 mg, 31%).  
1H NMR  (400 MHz, CDCl3): δ = 8.13 (2H, d; J = 16.7 Hz, CH), 7.66, 
7.63 (6H, m; 2H: CH, and 4H: ArH), 7.08 (2H, d; J = 16.5 Hz, CH), 7.01, 6.96 
(8H, m; ArH), 6.78 (4H, d; J = 8.8Hz, ArH),  6.49 (3H, s; ArH), 5.89 (2H, d; J = 
16.5 Hz, CH), 3.94 (4H, d; OCH2; J = 5.6Hz), 3.85 (4H, d; OCH2; J = 5.6Hz), 
3.65 (4H, t; J = 6.6 Hz, OCH2), 1.81- 1.72 (4H, m; CH), 1.54- 1.41 (12H, m; 
CH2), 1.39, 1.33(24H, m; CH2), 1.32-1.19 (28H, m; CH2), 0.95 (30H, m; CH3). 
13C NMR (100 MHz, CDCl3): δ = 161.5, 160.7, 159.7, 149.5, 140.3, 
139.4, 137.0, 136.1, 134.9, 132.4, 129.7, 129.3, 128.0, 118.3, 114.9, 114.4,  
  
108.5, 108.2, 105.8, 70.7, 70.6, 68.5, 39.4, 31.9, 31.6, 30.6, 29.6, 29.4, 29.11, 
25.9, 23.8, 23.0, 22.7, 14.1, 11.0 .  
MS (TOF  ESI): m/z: : Calcd: 1655.8712 [M]+, Found: 1655.8941 [M] , 
I=13.82 ppm.   
Figure 29. Synthesis of Compound 32 
 
 
  
 
3. CHAPTER 3 
 
RESULTS and DISCUSSIO 
3.1. General Perspective 
Photodynamic therapy is a growing field of treatment of cancer and gives 
promising results in clinical studies because photodynamic action allows local 
application on targeting areas, which are cancerous and noncancerous tissues, 
and gives minimum damage in surrounding area in contrast to other 
conventional treatments such as radiotherapy or chemotherapy. Besides, further 
selectivity is provided by exposing light to only targeting tissue. Efficiency of 
photodynamic action is dependent on how sufficiently cytotoxic effects are 
provided on the targeted tissues by singlet oxygen generation. Therefore, 
efficient singlet oxygen generation of photosensitizers is the crucial step on 
photodynamic applications.  
Here, we proposed two photodynamic therapy reagents based on Bodipy 
dye. Bodipy is preferred due to its photostability and it can be modified in a 
number of regions easily as it is mentioned in introductory part.  Bodipy core 
was synthesized through standard Bodipy reaction. 3,5-
bis(decyloxy)benzaldehyde is used as the aldehyde to increase the solubility of 
Bodipy derivative in organic solvents such as benzene or toluene.   
2, 6- positions were decorated with bromines in compound 31 and 32. Spin 
orbit perturbation is required for electronic transition between states of different 
spin multiplicities otherwise electronic transition occurs inefficiently. Spin orbit 
perturbation can be enhanced by heavy atoms in the environment, external heavy 
  
atom effect, or placing heavy atoms directly into core of molecule, internal 
heavy atom effect. Heavy atom effect can be defined as the increase of rates of 
inter system crossing due to influence of heavy atoms such as Br, I onto 
molecule. The efficiency of spin forbidden electronic transition from a singlet 
state to a triplet state, intersystem crossing, is highly important for the formation 
of singlet oxygen so the effectiveness of photosensitizers. We fused bromo 
substitutents on 2,-6,- positions of Bodipy core. Heavy atom effect on singlet 
oxygen generation of Bodipy dyes are studied by O’Shea et al.72. In their work, 
they used internal heavy atom effect and so they attached heavy atom at different 
positions on Bodipy derivative in order to observe the change of spin orbit 
couplings at different positions. In order to observe singlet oxygen generation 
efficiency, they synthesized three different aza-Bodipy derivatives. In the first 
derivative, no heavy atom is used, in the second derivative, heavy atoms, 
bromine atoms, are attached on the aryl rings not directly on the core of the 
photosensitizer and in the last one heavy atoms directly attached to 
photosensitizer core at 2-, 6- positions. Inherent spin orbit coupling of the first 
molecule does not change. In the second one, increase in intermediate singlet 
oxygen generation is provided due to intermolecular external effect and in the 
last Bodipy derivative, singlet oxygen generation is increased tremendously by 
internal heavy atom effect. The most efficient singlet oxygen generation is 
provided in the last Bodipy derivative. Therefore, in our design, we took 
advantage of internal heavy atom effect and we placed bromine atoms at 2,-6-  
positions of Bodipy core (Figure 30). 
 
  
Figure 30.Target photosensitizers 
 
Photosensitizer should also absorb light in the phototherapeutic window, 
620-850 nm, because light penetrates in a maximum depth in this range and also 
autofluorescence of tissues can be avoided. Therefore, photosensitizers that 
absorb light below 620 nm are not optimal for photodynamic action.  Tetrastyryl 
substitution on Bodipy core was one of the ways to extend absorption and 
emission maxima of Bodipy based dyes as it is mentioned before. We substituted 
Bodipy core at 1, 7, 3, 5- positions with 4-methoxybenzaldehyde for compound 
31 and 4-(2-ethylhexyloxy)benzaldehyde for compound 32. Maximum 
absorbance wavelengths of photosensitizers are determined to be 700 nm and 
704 nm in CHCl3 for compounds 31 and 32 respectively (Figure 31 and 32). The 
resulting wavelengths are very suitable for photodynamic therapy applications 
since penetration depth of light at this wavelength, light in near IR region, is 
considerably high. 
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Figure 31.Absorbance (solid line) and Emission (dashed line) spectrum of 
compound 31 in CHCl3 
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Figure 32. Absorbance (solid line) and Emission (dashed line) spectrum of compound 32 in 
CHCl3 
All the compounds obtained after each reaction were characterized using 
1H NMR, 13C NMR spectra and Mass spectrometry analysis. NMR spectra were 
measured using CDCl3 as solvent. All these data are provided in appendices A 
and B.  
3.2. Singlet Oxygen Generation: Degradation of tetrastyrl-
BODIPY dyes and 1,3-diphenyl-isobenzofuran under near-
IR light 
 
Singlet oxygen generation capability of compound 31 and 32 were 
measured by using 1,3-diphenylisobenzofuran (DPBF). Photosensitizers were 
excited at their maximum absorption wavelength, 700 nm light illumination for 
compound 31 and 704 nm light illumination for compound 32.  The light 
intensity was determined to be 0.2 mW/ cm2.  
Figure 
DPBF is used as a singlet oxygen trap. Therefore, photobleaching of 
DPBF is used to monitor singlet oxygen generation capability of synthesized 
photosensitizers. When singlet oxygen is generated as the excitation of 
photosensitizers, DPBF reacts with generated singlet oxygen as a result 
absorbance at 411 nm decreases
experiments were conducted in this solvent. 
50 µM of DPBF solution was monito
significant change is observed in absorbance of DPBF.
 
Figure 34. Excitation of photosensitizer
oxygen generation. Trap molecule reacts with singlet oxygen with a decrease in 
the absorption wavelength at 411 nm.
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33. 1,3-diphenylisobenzofuran (DPBF) 
 (Figure 32). DPBF is soluble in isoporopanol so 
In control experiment, absorption of 
red 25 minutes in dark. There is no 
 
 with near-IR light, resulting in singlet 
 
The experiment was performed with 50 
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Figure 35.  Bleaching of 50 µM DPBF in isopropanol in the presence of 
50  nM compound 31
irradiated with 700 nm light for 45 minutes. Absorbance was measured in 5 
minutes intervals. 
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Figure 36. Bleaching of 50 µM DPBF in isopropanol in the presence of 50  nM 
compound  32.  For the first 25 minutes sample was kept at dark, then irradiated 
with 704 nm light for 45 minutes. Absorbance was measured in 5 minutes 
intervals. 
 To sum up, we have synthesized 
photosensitizers. These photosensitizers with bromo substituents on Bodipy core 
are effective singlet oxygen generators. In addition, these dyes are optimal for 
biomedical applications with their near
dark toxicity. The activities of photosensitizers are effective under near
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-IR light.  
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CHAPTER 4 
 
COCLUSIO 
 
 
In this thesis study, two Bodipy based photodynamic therapy agents were 
synthesized and characterized. Through rational synthesis, photodynamic 
therapy requirements such as enhanced intersystem crossing and absorption in 
therapeutic range, near-IR absorption, are provided by bromine substitution on 
2,6-positions and tetra-styryl substitution on Bodipy core, respectively. Singlet 
oxygen generation experiments of synthesized compounds show that both of the 
compounds are efficient singlet oxygen generators in nanomolar concentrations. 
 In conclusion, we demonstrated tetrastyryl-Bodipy compounds can be 
synthesized in such a way that they perform as efficient photosensitizers for use 
in photodynamic therapy, with near IR excitability and high singlet oxygen 
generation capacity.  This is the first study of this novel class of near IR dyes 
towards photodynamic therapy applications.  Further work in transforming these 
derivatives to water soluble or amphiphilic compounds may yield novel 
candidates for photodynamic therapy.   
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APPEDIX A 
 
MR SPECTRA 
 
Figure 37. 
1H NMR spectrum of compound 25 
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Figure 38. 
13NMR spectrum of compound 25 
  
Figure 39. 
1H NMR spectrum of compound 26 
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Figure 40. 
13NMR spectrum of compound 26 
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Figure 41.
 1H NMR spectrum of compound 29 
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Figure 42. 
13NMR spectrum of compound 29 
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Figure 43. 
1H NMR spectrum of compound 31 
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Figure 44. 
13NMR spectrum of compound 31 
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Figure 45. 
1H NMR spectrum of compound 32 
  
Figure 46. 
13NMR spectrum of compound 32 
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APPENDIX B 
 
MASS SPECTRA 
 
47. ESI-HRMS of compound 25 
48. ESI-HRMS of compound 26 
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Figure 49. ESI-HRMS of compound 29 
Figure 50. ESI-HRMS of compound 31 
Figure 51. ESI-HRMS of compound 32 
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